682 related articles for article (PubMed ID: 34635137)
21. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.
Rüfenacht S; Gantenbein P; Boggian K; Flury D; Kern L; Dollenmaier G; Kohler P; Albrich WC
Infection; 2022 Jun; 50(3):783-790. PubMed ID: 35426564
[TBL] [Abstract][Full Text] [Related]
22. Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report.
Fujii H; Tsuji T; Sugitani M; Matsumoto Y; Yuba T; Tanaka S; Suga Y; Matsuyama A; Goda S; Omura A; Shiotsu S; Takumi C; Ono S; Hiraoka N
Curr Probl Cancer; 2021 Dec; 45(6):100739. PubMed ID: 33810911
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
24. Prolonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
Rogado J; Gullón P; Obispo B; Serrano G; Lara MÁ
Eur J Cancer; 2021 May; 148():58-60. PubMed ID: 33735810
[No Abstract] [Full Text] [Related]
25. A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
Gadzińska J; Kuchar E; Matysiak M; Wanke-Rytt M; Kloc M; Kubiak JZ
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e537-e538. PubMed ID: 33885040
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Chao JY; Derespina KR; Herold BC; Goldman DL; Aldrich M; Weingarten J; Ushay HM; Cabana MD; Medar SS
J Pediatr; 2020 Aug; 223():14-19.e2. PubMed ID: 32407719
[TBL] [Abstract][Full Text] [Related]
27. Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Weinbergerová B; Demel I; Víšek B; Válka J; Čerňan M; Jindra P; Novák J; Stejskal L; Kovácsová F; Kabut T; Szotkowski T; Hájek R; Žák P; Cetkovský P; Král Z; Mayer J
Hematol Oncol; 2022 Apr; 40(2):280-286. PubMed ID: 35120267
[TBL] [Abstract][Full Text] [Related]
28. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM;
JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939
[TBL] [Abstract][Full Text] [Related]
29. Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2.
Bormann M; van de Sand L; Witzke O; Krawczyk A
Klin Monbl Augenheilkd; 2021 May; 238(5):569-578. PubMed ID: 34020485
[TBL] [Abstract][Full Text] [Related]
30. Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of
Han YJ; Lee KH; Yoon S; Nam SW; Ryu S; Seong D; Kim JS; Lee JY; Yang JW; Lee J; Koyanagi A; Hong SH; Dragioti E; Radua J; Smith L; Oh H; Ghayda RA; Kronbichler A; Effenberger M; Kresse D; Denicolò S; Kang W; Jacob L; Shin H; Shin JI
Theranostics; 2021; 11(3):1207-1231. PubMed ID: 33391531
[No Abstract] [Full Text] [Related]
31. Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection - a single-center, retrospective, cohort study.
Kautsch K; Wiśniowska J; Friedman-Gruszczyńska J; Buda P
Eur J Pediatr; 2024 Feb; 183(2):591-598. PubMed ID: 37864601
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y
JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome.
Kim-Hellmuth S; Hermann M; Eilenberger J; Ley-Zaporozhan J; Fischer M; Hauck F; Klein C; Haas N; Kappler M; Huebner J; Jakob A; von Both U
J Pediatric Infect Dis Soc; 2021 Apr; 10(4):543-546. PubMed ID: 33188394
[TBL] [Abstract][Full Text] [Related]
34. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
[TBL] [Abstract][Full Text] [Related]
35. A young man presenting with encephalopathy and seizures secondary to SARS-CoV-2.
Jalil BA; Ijaz M; Khan AM; Ledbetter TG
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33762283
[TBL] [Abstract][Full Text] [Related]
36. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland.
Kuchar E; Załęski A; Wronowski M; Krankowska D; Podsiadły E; Brodaczewska K; Lewicka A; Lewicki S; Kieda C; Horban A; Kloc M; Kubiak JZ
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):541-547. PubMed ID: 32986153
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.
Wang M; Wu T; Zuo Z; You Y; Yang X; Pan L; Hu Y; Luo X; Jiang L; Xia Z; Deng M
BMJ Support Palliat Care; 2021 Mar; 11(1):45-52. PubMed ID: 32958501
[TBL] [Abstract][Full Text] [Related]
38. Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019: A Clinical Overview and Primer.
Knight TE
Biopreserv Biobank; 2020 Dec; 18(6):492-502. PubMed ID: 32726140
[TBL] [Abstract][Full Text] [Related]
39. Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Abraham RS; Marshall JM; Kuehn HS; Rueda CM; Gibbs A; Guider W; Stewart C; Rosenzweig SD; Wang H; Jean S; Peeples M; King T; Hunt WG; Honegger JR; Ramilo O; Mustillo PJ; Mejias A; Ardura MI; Shimamura M
J Allergy Clin Immunol; 2021 Feb; 147(2):532-544.e1. PubMed ID: 33007327
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]